English | Español
Patient Daily | Apr 17, 2026

Study highlights potential human health risk from rat hepatitis E virus
Patient Daily | Apr 17, 2026

Study reveals why immunotherapy fails in pancreatic cancer
Patient Daily | Apr 17, 2026

Genetic variants may reduce effectiveness of popular diabetes drugs
Patient Daily | Apr 17, 2026

AbbVie signs pain medicine deal with Haisco Pharmaceutical worth up to $715 million
Patient Daily | Apr 17, 2026

Regeneron announces partnership with Telix for radiopharmaceutical cancer therapies
Patient Daily | Apr 17, 2026

IDEAYA and Servier report positive trial results for metastatic eye cancer drug
Patient Daily | Apr 17, 2026

Replimune faces layoffs and site closures after FDA rejects melanoma drug again
Patient Daily | Apr 17, 2026

USP adds Tamiflu and Trulicity to list of drugs vulnerable to supply disruptions

Trending
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Regulatory
A. R. Baird | Jun 15, 2026

Health care reform group launches campaign linking consolidation to rising costs
+ Pharmaceuticals
Patient Daily | Jun 16, 2026

Intellia gene editing therapy shows strong results in hereditary angioedema study
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

PwC reports strong biopharma M&A activity as sector shifts to precision science